Trial intelligence / Profile preview

GSK576389A Influenza Vaccine in Adults 65+

NCT00540592Phase 2Completed

Sponsor
GSK
Start
Oct 2007
Primary completion
Jun 2008
Modality
Vaccines & Immunotherapeutics
Countries
4
01

Overview

A Phase 2 trial of GSK576389A in influenza, sponsored by GSK. Started Oct 2007; status: completed.

02

Drugs

GSK576389A
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00540592.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00540592.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call